JANUS HENDERSON GROUP PLC - CLEMENTIA PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of CLEMENTIA PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$53,515,000
+116.2%
2,050,389
-2.6%
0.03%
+87.5%
Q4 2018$24,755,000
+28.2%
2,105,040
+21.6%
0.02%
+60.0%
Q3 2018$19,303,000
-16.0%
1,731,192
-0.9%
0.01%
-23.1%
Q2 2018$22,981,000
-13.8%
1,746,296
-0.7%
0.01%
-18.8%
Q1 2018$26,655,000
+26.2%
1,759,408
+58.1%
0.02%
+23.1%
Q4 2017$21,124,000
+64.6%
1,112,949
+46.5%
0.01%
+62.5%
Q3 2017$12,833,000759,7920.01%
Other shareholders
CLEMENTIA PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Orbimed Advisors 10,425,225$197,871,0002.50%
NEA Management Company, LLC 2,141,697$40,649,0001.68%
RA Capital Management 585,403$11,111,0000.93%
DRIEHAUS CAPITAL MANAGEMENT LLC 862,279$16,366,0000.62%
DAFNA Capital Management LLC 60,000$1,139,0000.61%
EcoR1 Capital, LLC 194,166$3,685,0000.42%
SPHERA FUNDS MANAGEMENT LTD. 163,000$3,094,0000.36%
Rock Springs Capital Management LP 345,000$6,548,0000.30%
Birchview Capital, LP 22,000$418,0000.24%
SECTORAL ASSET MANAGEMENT INC 75,313$1,429,0000.18%
View complete list of CLEMENTIA PHARMACEUTICALS IN shareholders